Precision medicine for pediatric and adolescent acute leukemia
Description of the granted funding
The treatment of acute leukemia in children and adolescents is lenghty and causes a wide variety of short- and long-term adverse events. Moreover, despite intensive treatments, some patients experience a relapse. In this research project, we aim to elucidate the detailed mechanisms of acute leukemia by which the disease arises and resists therapies. Based on these findings, we seek novel precision therapies, especially for patients with a high risk for disease relapse. The research is being conducted together with many international collaborations and utilizes animal models of leukemia and drug screening settings in addition to cell culture models and patient samples.
Show moreStarting year
2021
End year
2025
Granted funding
Funder
Research Council of Finland
Funding instrument
Clinical researcher
Other information
Funding decision number
341540
Fields of science
Biomedicine
Research fields
Biolääketieteet
Identified topics
cancer